Is SGEN Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards Seagen Inc. (NASDAQ:SGEN) and determine whether it is a good investment...
Posts Tagged ‘NASDAQ:SGEN’
Carillon Tower Remains Optimistic in Seagen (SGEN) Despite its Poor Performance
Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Mid Cap Growth Fund” investor letter –...
5 Fastest Growing Biotech Companies in the US
In this article we discuss the 5 Fastest Growing Biotech Companies in the US. If you want to read our detailed analysis of the biotech industry and why...
Were Hedge Funds Right About Warming Up To Seagen Inc. (SGEN)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 823...
Hedge Funds Never Been This Bullish On Seattle Genetics, Inc. (SGEN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Did Hedge Funds Make The Right Call On Seattle Genetics, Inc. (SGEN) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However...
Hedge Fund and Insider Trading News: Steve Cohen, Anthony Scaramucci, Angelo, Gordon & Co., Conagra Brands Inc (CAG), McCormick & Company, Incorporated (MKC), and More
Warren Buffett, Howard Marks, Ray Dalio: What Top Investors are Saying About the Stock Market (CNBC) The stock markets have been seesawing and many experts...
Do Hedge Funds Love Seattle Genetics, Inc. (SGEN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Hedge Funds Have Never Been This Bullish On Seattle Genetics, Inc. (SGEN)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
How Did Seattle Genetics, Inc. (SGEN) Compare Against Top Hedge Fund Stocks in 2019?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Hedge Funds Had Impeccable Timing Buying Seattle Genetics, Inc. (SGEN)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Hedge Fund and Insider Trading News: Jim Simons, Nelson Peltz, Baker Bros. Advisors, Facebook Inc (FB), Covenant Transportation Group, Inc. (CVTI), and More
How Jim Simons Built the World’s Most Lucrative Black Box (Bloomberg) Anyone looking to learn how a quant fund conquered the financial world should...
Did Hedge Funds Drop The Ball On Seattle Genetics, Inc. (SGEN) ?
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (...
Here’s What Hedge Funds Think About Seattle Genetics, Inc. (SGEN)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Were Hedge Funds Right About Buying Seattle Genetics, Inc. (SGEN)?
“October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers...
Hedge Funds Are Dumping Seattle Genetics, Inc. (SGEN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity...
Hedge Fund and Insider Trading News: Dan Loeb, Michael Platt, Rapid7 Inc (RPD), Seattle Genetics, Inc. (SGEN), PHI Group, Inc. (PHIL), and More
‘There’s Finally an Alternative to Equities,’ Says Billionaire Fund Manager (MarketWatch) The stock market’s main gauges will rack up weekly gains...
Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More
Einhorn Says Greenlight Underperformance Is Worst Since 2000 (Bloomberg) Hedge fund manager David Einhorn said a shift in favor of value stocks may soon...
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors...
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Hedge Funds Are Coming Back to Seattle Genetics, Inc. (SGEN)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research...
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California. Prior to founding Blue Jay...
Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake
Julian and Felix Baker‘s Baker Bros. Advisors reported raising its stake in Seattle Genetics Inc (NASDAQ:SGEN) to 44.35 million common shares,...
Delving Into Seattle Genetics, Inc. (SGEN)’s Upcoming Readout
Seattle Genetics, Inc. (NASDAQ:SGEN) just reported second quarter financials, and the company is up nearly 10% on the data. Alongside the numbers, however...
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
13D Filing: Baker Bros. Advisors Buys More Shares of Seattle Genetics Inc (SGEN)
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the...
Billionaire Christian Leone Boosts Stake in This TV Station Operator, Nelson Peltz Lifts Stake in Struggling Pentair plc. (PNR), Plus 2 Other Moves
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should...
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Here is What Hedge Funds Think About Seattle Genetics, Inc. (SGEN)
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply...
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded...
Strong Insider Selling Activity Detected: Cheniere Energy Inc. (LNG) and Others
Generally, insider trading activity represents an important tool in the process of fundamental security analysis, as it can offer some insights on how...
Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In...
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued...
Felix Baker’s Baker Bros. Advisors Raises Positions In These Stocks
In several new filings with the Securities and Exchange Commission, Julian and Felix Bakers‘ healthcare-focused fund Baker Bros. Advisors reported...
Recent Multi-Millionaire Insider Purchases: Kinder Morgan (KMI), TransDigm Group (TDG), Seattle Genetics (SGEN)
Over the past week, a few multi millionaire insider purchases caught my eye. In this article, I will look into three particular companies that saw their...
Baker Bros. Advisors Ups Stake in Seattle Genetics Inc. (SGEN)
Baker Bros. Advisors, managed by Julian Baker and Felix Baker, have disclosed raising its stake in Seattle Genetics Inc. (NASDAQ:SGEN). In a new filing...
Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%
Julian and Felix Baker‘s Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares...
Baker Bros. Strengthens Position in Seattle Genetics, Inc. (SGEN)
Julian Baker and Felix Baker have increased their exposure to Seattle Genetics, Inc. (NASDAQ:SGEN) even higher. In a newly amended filing with the SEC...
Baker Bros Advisors Increases Stake in Seattle Genetics Inc (SGEN)
Julian Baker and Felix Baker are betting big on Seattle Genetics, Inc. (NASDAQ:SGEN). In a recent Form 4 filing with the Securities and Exchange Commission...
Hedge Fund News: Bill Miller, Richard Perry & Alphonse Fletcher
Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary...
MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors
In pharmacology, we don’t only have to consider the actions of the drug on the body. It is also important to understand the way the body processes...
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment...
Pfizer Inc. (PFE): Is Seattle Genetics (SGEN) an Acquisition Target?
In late August, Amgen agreed to buy Onyx Pharmaceuticals in one of the worst-kept M&A secrets of the year. Amgen paid 50% more than Onyx’s pre...
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for...
